NEW YORK, June 26, 2015 /PRNewswire/ -- Faruqi &
Faruqi, LLP, a leading national securities firm headquartered in
New York City, is investigating
the Board of Directors of KYTHERA Biopharmaceuticals, Inc.
("Kythera" or the "Company") (NasdaqGS: KYTH) for potential
breaches of fiduciary duties in connection with the sale of the
Company to Allergan plc. for approximately $2.1 billion. The Company's stockholders
will only receive approximately $75
per share for each share of Kythera common stock they own.
The fixed-value transaction consideration will be payable 80
percent in cash and 20 percent in new Allergan shares issued to
Kythera shareholders. However, at least one analyst has set a price
target of $85.00 for shares of the
Company.
Click here for more information:
www.faruqilaw.com/KYTH. There is no cost or obligation to
you.
The investigation focuses on whether Kythera's Board of
Directors breached their fiduciary duties to the Company's
stockholders by failing to conduct a fair sales process and whether
and by how much this proposed transaction undervalues the Company
to the detriment of Kythera's shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The
firm is focused on providing exemplary legal services in complex
litigation in the areas of securities, shareholder, antitrust and
consumer litigation, throughout all phases of litigation. The
firm has an experienced trial team which has achieved significant
victories on behalf of the firm's clients. To keep track of the
latest securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
If you own common stock in Kythera and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/KYTH or contact Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Contact:
Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330
Attorney Advertising. (C) 2015 Faruqi & Faruqi, LLP.
The law firm responsible for this advertisement is Faruqi &
Faruqi, LLP (www.faruqilaw.com). Prior results do not
guarantee or predict a similar outcome with respect to any future
matter. We are happy to discuss your particular case.
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kythera-shareholder-alert-faruqi--faruqi-llp-announces-the-investigation-of-kythera-biopharmaceuticals-inc-kyth-over-the-proposed-sale-of-the-company-to-allergan-plc-300105728.html
SOURCE Faruqi & Faruqi, LLP